Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.
暂无分享,去创建一个
M. Hannan | J. Miro | D. Murdoch | J. Strahilevitz | P. Tattevin | Z. Kanafani | J. Pericàs | E. Athan | V. Chu | T. Freiberger | E. Durante-Mangoni | N. Fernández-Hidalgo | C. Lamas | M. Hernández-Meneses | F. Nacinovich | J. Llopis | N. Fernández-hidalgo
[1] K. Witte,et al. Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] G. Aurigemma,et al. Infective endocarditis among persons aged 18-64 years with HIV, hepatitis C infection, or opioid use disorder - United States, 2007-2017. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] W. Tan,et al. Left-sided infective endocarditis in persons who inject drugs , 2020, Infection.
[4] J. Miro,et al. A Contemporary Picture of Enterococcal Endocarditis. , 2020, Journal of the American College of Cardiology.
[5] M. Stein,et al. Outcomes Associated with Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] M. Sohail,et al. Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States. , 2020, Mayo Clinic proceedings.
[7] T. Korman,et al. Burden of infective endocarditis in an Australian cohort of people who inject drugs , 2019, Internal medicine journal.
[8] Mylan C. Cohen,et al. Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services , 2019, PloS one.
[9] P. Benharash,et al. Infective endocarditis in intravenous drug users. , 2019, Trends in cardiovascular medicine.
[10] O. Alfieri,et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. , 2019, European heart journal.
[11] M. Silverman,et al. Recurrent Endocarditis in Persons Who Inject Drugs , 2019, Open forum infectious diseases.
[12] Alex A. T. Bui,et al. Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis , 2019, BMC Infectious Diseases.
[13] M. Mori,et al. Recidivism Is the Leading Cause of Death Among Intravenous Drug Users Who Underwent Cardiac Surgery for Infective Endocarditis. , 2019, Seminars in Thoracic and Cardiovascular Surgery.
[14] N. Adhikari,et al. Clinical and echocardiographic predictors of embolism in infective endocarditis: systematic review and meta-analysis. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] A. Garg,et al. The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis , 2019, Canadian Medical Association Journal.
[16] M. Silverman,et al. Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject Drugs , 2018, JAMA network open.
[17] Sadeer G. Al-Kindi,et al. Changes in the Association of Rising Infective Endocarditis With Mortality in People Who Inject Drugs , 2018, JAMA cardiology.
[18] Andrew Wang,et al. Management Considerations in Infective Endocarditis: A Review , 2018, JAMA.
[19] W. Schaffner,et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016 , 2018, MMWR. Morbidity and mortality weekly report.
[20] M. Khan,et al. Admissions for Infective Endocarditis in Intravenous Drug Users. , 2018, Journal of the American College of Cardiology.
[21] O. Weiland,et al. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs , 2016, Medicine.
[22] M. Hannan,et al. Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis , 2016, Antimicrobial Agents and Chemotherapy.
[23] D. Snydman,et al. Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs , 2016, Open forum infectious diseases.
[24] E. Athan,et al. Evolving epidemiology of injecting drug use-associated infective endocarditis: A regional centre experience. , 2015, Drug and alcohol review.
[25] V. Figueredo,et al. Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review , 2013, PloS one.
[26] Gilbert Habib,et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. , 2009, Annals of internal medicine.
[27] Andrew Wang,et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. , 2009, Archives of internal medicine.
[28] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[29] E. Cecchi,et al. Infective Endocarditis in Intravenous Drug Users from Italy: the Increasing Importance in HIV-infected Patients , 2007, Infection.
[30] J. Miro,et al. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. , 2002, Infectious disease clinics of North America.
[31] C. Cabell,et al. Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. , 2002, Infectious disease clinics of North America.
[32] V. Fowler,et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] J. Mathew,et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. , 1995, Archives of internal medicine.
[34] N. Reiner,et al. Enterococcal endocarditis in heroin addicts. , 1976, JAMA.